L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00125788
Recruitment Status : Completed
First Posted : August 2, 2005
Last Update Posted : August 9, 2017
FDA Office of Orphan Products Development
Information provided by (Responsible Party):
Emmaus Medical, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2008
  Actual Study Completion Date : July 2008
  Certification/Extension First Submitted : November 17, 2011